Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.115 USD | -4.29% | -16.18% | +35.96% |
05:23pm | X4 Pharmaceuticals' Xolremdi Approved by FDA For WHIM Syndrome | MT |
02:30pm | Transcript : X4 Pharmaceuticals, Inc. - Special Call |
- Stock Market
- Equities
- XFOR Stock
- News X4 Pharmaceuticals, Inc.
- Trading Ideas